Menu Back to Conference

About DIA 2023


For more than 50 years, DIA has been dedicated to providing a neutral and transparent global forum for the exchange of ideas and collaborations to further scientific and medical innovations. Fueled by the ideas of thousands of attendees, the DIA 2023 Global Annual Meeting will bring industry, regulators, academics, and patients together to co-create, problem-solve, and discuss global and local challenges facing professionals in the life sciences community.

DIA 2023 is the essential meeting for catalyzing knowledge creation and sharing to accelerate healthcare product development. It is an unparalleled experience combining education and networking opportunities that will elevate your skills and knowledge.

Need approval in order to attend the largest life sciences meeting globally? Download and fill out our Justification letter to demonstrate to your supervisor why this is a must-attend event.

The goal of the DIA 2023 Global Annual Meeting is to amplify different voices, highlight expertise across the globe, bring together experts to solve problems and reimagine current processes to enhance health and well-being, while keeping our key tenets in mind:

  • That patients are our story
  • That we seek to understand
  • That collaboration is the skill we hone
  • That this collaboration must cross organizations, decades, languages, and boundaries to have true global impact

You will find an array of diverse perspectives across our thirteen education tracks, dedicated networking, continuing education opportunities, and a dynamic exhibit hall. By joining us, you will be immersed in conversations with leaders from around the globe with the same common goal – to advance science and fuel innovation that directly impacts public health.

Get Ready for the DIA 2023 Global Annual Meeting

Access Recordings from the Top 5 Sessions Attended Last Year

  1. New Tools for Creating Flexible and Sustainable Master Protocols
  2. Meeting Regulatory Expectations: What Needs to be Considered When Using Digital Technologies to Generate Clinical Evidence?
  3. Support of IND Safety Reporting by the Aggregate Safety Assessment Plan (ASAP)
  4. Strategic Planning in Selecting the Right Countries and Sites for Clinical Trials
  5. Planning and Conducting Efficient, High-Quality Decentralized Trials: A Multi-Stakeholder Initiative

Download Now

Registration Rates

Back to DIA 2023

Back to